Bio Essence Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bio Essence Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q2 2024.
  • Bio Essence Corp Deferred Tax Assets, Valuation Allowance for the quarter ending June 30, 2024 was $624K, a 61% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $624K -$976K -61% Jun 30, 2024 10-Q/A 2024-10-30
Q1 2024 $564K -$971K -63.3% Mar 31, 2024 10-Q/A 2024-10-30
Q4 2023 $635K -$850K -57.2% Dec 31, 2023 10-Q/A 2024-10-30
Q3 2023 $1.67M +$245K +17.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.6M +$297K +22.8% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.53M +$276K +21.9% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.48M +$288K +24.1% Dec 31, 2022 10-K 2024-04-15
Q3 2022 $1.43M -$226K -13.7% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.3M -$307K -19.1% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.26M -$307K -19.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $1.2M -$311K -20.6% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.65M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.61M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.57M Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $1.51M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.